Jazz Pharmaceuticals' Lung Cancer Setback: Stock Impact
A late-stage setback for Jazz Pharmaceuticals' lung cancer drug Zepzelca rattled investors, but the larger story may ...
Short term financial aid is available to those in need. Find out where to access assistance and improve your situation.
27,173 articlesA late-stage setback for Jazz Pharmaceuticals' lung cancer drug Zepzelca rattled investors, but the larger story may ...
Could Energy Transfer (ET) outpace the broad market in the second half of 2026? This article builds a practical, data...
Dividend income can be a reliable part of a retirement plan. This guide shows the math behind earning $12,000 annuall...
A major corporate Bitcoin holder expands its BTC stake during a market pullback, widening unrealized losses but under...
A single hedge fund exit can move a stock as much as a major earnings beat. This guide breaks down a $34 million TDS ...
MP Materials is turning a quiet corner in the US defense supply chain, with Pentagon-backed pricing and a plan to bui...
Bitcoin hovers around $70,000 after a brief pullback, as volatility eases and traders weigh whether this is the momen...
Ripple's XRP briefly breached the $1.50 threshold but failed to sustain gains, renewing questions about the next majo...
CVS Health will broaden coverage for Lilly’s GLP-1 medications, including the new pill Foundayo and Zepbound injectio...
With the Social Security trust fund projected to run dry by the early 2030s, Congress faces a high-stakes fight over ...
Broadcom is pursuing a bold AI compute strategy that could reshape its growth trajectory. This article breaks down th...
Choosing the right pharmaceutical ETF can shape your portfolio’s risk and income. This guide pits IHE against PJP, br...